ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
596 hedge funds and large institutions have $23.4B invested in Alexion Pharmaceuticals Inc in 2018 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 219 increasing their positions, 225 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
596
Holders Change
+10
Holders Change %
+1.71%
% of All Funds
13.68%
Holding in Top 10
16
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.88%
% of All Funds
0.37%
New
81
Increased
219
Reduced
225
Closed
63
Calls
$468M
Puts
$434M
Net Calls
+$34.2M
Net Calls Change
+$82.4M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$275M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$180M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$134M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$110M |
| 5 |
Millennium Management
New York
|
+$99.7M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$193M |
| 2 |
Goldman Sachs
New York
|
-$187M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$144M |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$124M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$107M |
